Reported results
- Net revenues were $2.4 million, down 51% from $4.9 million in the third quarter of 2025.
- Total GAAP operating expenses were $5.1 million, down 8% from $5.6 million in the third quarter of 2025.
- GAAP loss from operations was $2.7 million, compared with a loss from operations of $0.7 million in the third quarter of 2025.
- GAAP net loss from continuing operations was $2.8 million, or $(0.25) per basic and diluted share, compared to net income from continuing operations of $2.9 million, or $0.34 basic and $0.31 diluted per share, in the third quarter of 2025.
- Non-GAAP Adjusted EBITDA was negative $2.1 million, compared to negative $0.2 million in the third quarter of 2025.
- Cash and cash equivalents excluding restricted cash were $13.4 million as of September 30, 2026.
Guidance
- The Company expects its cash and cash equivalents of $13.4 million to be sufficient to fund operations for at least the next twelve months.
Notes
In October 2026, the Company filed amended quarterly reports for the first and second quarters of 2026 to correct the accounting for approximately $1.0 million of non-cash placement-agent warrant costs.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.
